BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28028754)

  • 1. Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice with Experimental Sepsis.
    Ahn WG; Jung JS; Kwon HY; Song DK
    Inflammation; 2017 Apr; 40(2):537-545. PubMed ID: 28028754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes.
    Sevastou I; Kaffe E; Mouratis MA; Aidinis V
    Biochim Biophys Acta; 2013 Jan; 1831(1):42-60. PubMed ID: 22867755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation.
    Trovato FM; Zia R; Napoli S; Wolfer K; Huang X; Morgan PE; Husbyn H; Elgosbi M; Lucangeli M; Miquel R; Wilson I; Heaton ND; Heneghan MA; Auzinger G; Antoniades CG; Wendon JA; Patel VC; Coen M; Triantafyllou E; McPhail MJ
    Hepatology; 2021 Aug; 74(2):907-925. PubMed ID: 33908067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.
    Law SH; Chan ML; Marathe GK; Parveen F; Chen CH; Ke LY
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
    Uranbileg B; Ito N; Kurano M; Saigusa D; Saito R; Uruno A; Kano K; Ikeda H; Yamada Y; Sumitani M; Sekiguchi M; Aoki J; Yatomi Y
    Sci Rep; 2019 Nov; 9(1):16578. PubMed ID: 31719574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure.
    Trovato FM; Zia R; Artru F; Mujib S; Jerome E; Cavazza A; Coen M; Wilson I; Holmes E; Morgan P; Singanayagam A; Bernsmeier C; Napoli S; Bernal W; Wendon J; Miquel R; Menon K; Patel VC; Smith J; Atkinson SR; Triantafyllou E; McPhail MJW
    J Hepatol; 2023 Mar; 78(3):558-573. PubMed ID: 36370949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomic analysis of plasma lipids composition changes in septic mice.
    Ahn WG; Jung JS; Song DK
    Korean J Physiol Pharmacol; 2018 Jul; 22(4):399-408. PubMed ID: 29962854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat.
    Sekas G; Patton GM; Lincoln EC; Robins SJ
    J Lab Clin Med; 1985 Feb; 105(2):190-4. PubMed ID: 3973457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lysophosphatidic acid increase by prestorage whole blood leukoreduction in autologous CPDA-1 whole blood.
    Nagura Y; Tsuno NH; Ohkawa R; Nojiri T; Tokuhara Y; Matsuhashi M; Yatomi Y; Takahashi K
    Transfusion; 2013 Dec; 53(12):3139-48. PubMed ID: 23461375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.
    Nakamura K; Kishimoto T; Ohkawa R; Okubo S; Tozuka M; Yokota H; Ikeda H; Ohshima N; Mizuno K; Yatomi Y
    Anal Biochem; 2007 Aug; 367(1):20-7. PubMed ID: 17568554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lysophosphatidic acid is produced through diverse phospholipase pathways.
    Aoki J; Taira A; Takanezawa Y; Kishi Y; Hama K; Kishimoto T; Mizuno K; Saku K; Taguchi R; Arai H
    J Biol Chem; 2002 Dec; 277(50):48737-44. PubMed ID: 12354767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of lysophosphatidylcholine in experimental sepsis.
    Yan JJ; Jung JS; Lee JE; Lee J; Huh SO; Kim HS; Jung KC; Cho JY; Nam JS; Suh HW; Kim YH; Song DK
    Nat Med; 2004 Feb; 10(2):161-7. PubMed ID: 14716308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
    Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
    J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of lysophosphatidylcholine accumulation in the ischemic canine heart.
    Mock T; Man RY
    Lipids; 1990 Jul; 25(7):357-62. PubMed ID: 2395414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin-lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.
    Janovicz A; Majer A; Kosztelnik M; Geiszt M; Chun J; Ishii S; Tigyi GJ; Benyó Z; Ruisanchez É
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1887-1894. PubMed ID: 37837357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
    Inoue M; Ma L; Aoki J; Ueda H
    J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.
    Michalczyk A; Dołęgowska B; Heryć R; Chlubek D; Safranow K
    Lipids Health Dis; 2019 Apr; 18(1):85. PubMed ID: 30947711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.